HealthJul 8, 2026FDA Panel Considers Reclassifying Popular PeptidesFederal regulators are weighing whether to allow compounding pharmacies to manufacture seven popular injectable peptides (including BPC-157, TB-500 and MOTs-C) that ...Peptide therapiesFood and Drug Administration (FDA)Robert F. Kennedy
